Stress regulates endocannabinoid-CB1 receptor signaling

被引:77
|
作者
Hillard, Cecilia J. [1 ,2 ]
机构
[1] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA
关键词
Cannabinoid; Endocannabinoid; Stress; Glucocorticoid; CANNABINOID CB1 RECEPTOR; ACID AMIDE HYDROLASE; CHRONIC UNPREDICTABLE STRESS; PITUITARY-ADRENAL AXIS; CENTRAL-NERVOUS-SYSTEM; CHRONIC MILD STRESS; RESTRAINT STRESS; RAT-BRAIN; ENDOGENOUS CANNABINOIDS; PERIAQUEDUCTAL GRAY;
D O I
10.1016/j.smim.2014.04.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The CB1 cannabinoid receptor is a G protein coupled receptor that is widely expressed throughout the brain. The endogenous ligands for the CB1 receptor (endocannabinoids) are N-arachidonylethanolamine and 2-arachidonoylglycerol; together the endocannabinoids and CB1R subserve activity dependent, retrograde inhibition of neurotransmitter release in the brain. Deficiency of CB1 receptor signaling is associated with anhedonia, anxiety, and persistence of negative memories. CB1 receptor-endocannabinoid signaling is activated by stress and functions to buffer or dampen the behavioral and endocrine effects of acute stress. Its role in regulation of neuronal responses is more complex. Chronic variable stress exposure reduces endocannabinoid-CB1 receptor signaling and it is hypothesized that the resultant deficiency in endocannabinoid signaling contributes to the negative consequences of chronic stress. On the other hand, repeated exposure to the same stress can sensitize CB1 receptor signaling, resulting in dampening of the stress response. Data are reviewed that support the hypothesis that CB1 receptor signaling is stress responsive and that maintaining robust endocannabinoid/CB1 receptor signaling provides resilience against the development of stress-related pathologies. (C) 2014 Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:380 / 388
页数:9
相关论文
共 50 条
  • [31] The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets
    Bambico, Francis Rodriguez
    Gobbi, Gabriella
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (11) : 1347 - 1366
  • [32] Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor
    Porter, AC
    Sauer, JM
    Knierman, MD
    Becker, GW
    Berna, MJ
    Bao, JQ
    Nomikos, GG
    Carter, P
    Bymaster, FP
    Leese, AB
    Felder, CC
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (03): : 1020 - 1024
  • [33] The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation
    Watson, Sheona
    Chambers, David
    Hobbs, Carl
    Doherty, Patrick
    Graham, Anthony
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2008, 38 (01) : 89 - 97
  • [34] Endocannabinoid system in Xenopus laevis development:: CB1 receptor dynamics
    Beatrice, M
    Gabriella, M
    Francesca, G
    Oliana, C
    FEBS LETTERS, 2006, 580 (08) : 1941 - 1945
  • [35] Cannabinoid CB1 and CB2 Receptor Signaling and Bias
    Ibsen, Mikkel Soes
    Connor, Mark
    Glass, Michelle
    CANNABIS AND CANNABINOID RESEARCH, 2017, 2 (01) : 48 - 60
  • [36] Cannabinoid Receptor Interacting Protein 1a (CRIP1a) regulates CB1 signaling and transcriptional activity
    Blume, Lawrence Christopher
    Bass, Caroline E.
    Dalton, George D.
    Selley, Dana E.
    Howlett, Allyn C.
    FASEB JOURNAL, 2012, 26
  • [37] Neural endocannabinoid CB1 receptor expression, behavior in male European starlings
    DeVries, M. Susan
    Cordes, Melissa A.
    Rodriguez, Jonathan D.
    Stevenson, Sharon A.
    Riters, Lauren V.
    BRAIN RESEARCH, 2016, 1644 : 240 - 248
  • [38] Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy
    Fabio A. Iannotti
    Ester Pagano
    Ombretta Guardiola
    Simone Adinolfi
    Valentina Saccone
    Silvia Consalvi
    Fabiana Piscitelli
    Elisabetta Gazzerro
    Giuseppe Busetto
    Diego Carrella
    Raffaele Capasso
    Pier Lorenzo Puri
    Gabriella Minchiotti
    Vincenzo Di Marzo
    Nature Communications, 9
  • [39] Endocannabinoid CB-1-receptor agonism attenuates amygdala-kindling progression
    Wendt, H.
    Soerensen, J.
    Wotjak, C. T.
    Potschka, H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2010, 381 : 46 - 46
  • [40] Characterization of the endocannabinoid system, CB1 receptor signalling and desensitization in human myometrium
    Brighton, Paul J.
    Marczylo, Timothy H.
    Rana, Shashi
    Konje, Justin C.
    Willets, Jonathon M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (05) : 1479 - 1494